Inventor

LI PENG

CN694 patents

⚠️ This page may combine multiple inventors who share the name “LI PENG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LI PENG

INTRA CELLULAR THERAPIES INC

Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof

Substituted pyrido[3&#39;,4&#39;:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity

Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders

Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereof

Methods of treating bipolar disorder

Methods of treating schizophrenia and depression

Pharmaceutical compositions for sustained or delayed release

Organic compounds

Pharmaceutical compositions comprising 4-(6BR,10AS)-3-methyl-2,3,6B,9,10,10A-hexahydro-1h, 7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one and methods of treating conditions of the central nervous system

Transmucosal and subcutaneous compositions

Organic compounds

Organic compounds

Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3&#39;,4&#39;:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity

Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereof

Methods

Organic compounds

Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereof

Organic compounds

Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity

Method for the treatment of residual symptoms of schizophrenia

Organic compounds

Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders

Pharmaceutical capsules comprising lumateperone mono-tosylate

Pharmaceutical capsule compositions comprising lumateperone mono-tosylate

Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate

Transmucosal methods for treating psychiatric and neurological conditions

Organic compounds

Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3′, 4′, 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous system

Organic compounds

LI PENG

Organic compounds

Organic compounds

Organic compounds

Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-ones

Organic compounds

Organic compounds

Organic compounds

SHENZHEN DO INTELLIGENT TECH CO LTD

Smartwatch

Smart watch

Smart watch

Wrist watch

Smartwatch

AMERICAN JEREH INT CORPORATION

Status monitoring and failure diagnosis system for plunger pump

Status monitoring and failure diagnosis system for plunger pump

High-low pressure lubrication system for high-horsepower plunger pump

TOMESCH JOHN CHARLES

Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereof

Substituted heterocycle gamma-carbolines synthesis

MATES SHARON

Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives

QUALCOMM INC

Method and apparatus for allocating data streams given transmission time interval (TTI) constraints

YANTAI JEREH PETROLEUM EQUIPMENT & TECHNOLOGIES CO LTD

Valve spring seat sleeve, valve assembly and plunger pump

MUI LIK

System and method for page navigation visualization and analysis

Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity

Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activity